Clinical Trials Sponsored by Koneksa Health

Total 50342 results

Koneksa Health

Recruiting

Twenty-Four Seven Functional Status in Total Hip Replacement (LEARNT)

Total Hip Replacement

United States
Koneksa Health

Completed

Study Comparing At-Home Mobile Spirometry to In-Clinic in Moderate Asthma Participants Taking Long-Acting Beta Agonist (LEARN)

Moderate Asthma

United States
Koneksa Health
Merck Sharp & Dohme LLC

Recruiting

Parkinson's Disease Progression Study

Parkinson Disease

United States
Scripps Health
Kaneka Corporation

Recruiting

Effects of a Multispecies Probiotic on Migraine

Irritable Bowel Syndrome | Migraine | Headache, Migraine

United States
Northwestern University
Michael J. Fox Foundation for Parkinson's Research; Koneksa Health

Recruiting

A Novel Measurement Concept to Objectively Quantify Severity of Vocal and Speech Related Symptoms Associated With Parkinson's Disease (Voice-PD)

Parkinson Disease

United States
Kiniksa Pharmaceuticals (UK), Ltd.

Completed

Study to Assess the Efficacy and Safety of Rilonacept Treatment in Participants With Recurrent Pericarditis (RHAPSODY)

Recurrent Pericarditis

United States, Israel, Australia, Italy
Kiniksa Pharmaceuticals (UK), Ltd.

Recruiting

REgiStry Of the NAtural History of recurreNt periCarditis in pEdiatric and Adult Patients (RESONANCE)

Recurrent Pericarditis

United States
Kiniksa Pharmaceuticals (UK), Ltd.

Completed

A Pilot Study of KPL-914 in Recurrent Pericarditis

Recurrent Pericarditis

United States
Kiniksa Pharmaceuticals, Ltd.

Active, not recruiting

Study to Assess the Safety, Pharmacokinetics, and Efficacy of KPL-404 in Participants With Rheumatoid Arthritis With Inadequate Response or Intolerance to at Least One Biologic Disease-modifying Anti-rheumatic Drug or a Janus Kinase Inhibitor

Arthritis, Rheumatoid

United States, Poland, Hungary, Georgia, Czechia, South Africa, Bulgaria
Kiniksa Pharmaceuticals, Ltd.

Completed

Study to Assess the Efficacy, Safety, and Tolerability of Vixarelimab in Reducing Pruritus in Prurigo Nodularis

Prurigo Nodularis | Pruritis

United States, Australia, Austria, Belgium, Canada, Czechia, France, Germany, Italy, Korea, Republic of, Poland, Taiwan, United Kingdom
Kiniksa Pharmaceuticals, Ltd.

Completed

A Study to Assess the Efficacy, Safety, and Tolerability of KPL-716 in Reducing Pruritus in Chronic Pruritic Diseases

Plaque Psoriasis | Chronic Idiopathic Urticaria | Lichen Planus | Lichen Simplex Chronicus | Chronic Idiopathic Pruritus

United States
Kiniksa Pharmaceuticals, Ltd.

Completed

Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses of KPL-404 in Healthy Subjects

Healthy Volunteers

Australia, United States
Kiniksa Pharmaceuticals, Ltd.

Completed

KPL-301 for Subjects With Giant Cell Arteritis

Giant Cell Arteritis

United States, Belgium, Croatia, Germany, Italy, Poland, Serbia, United Kingdom, Australia, Estonia, Ireland, Netherlands, New Zealand, Slovenia, Spain
Kiniksa Pharmaceuticals, Ltd.

Completed

Study of Mavrilimumab (KPL-301) in Participants Hospitalized With Severe Corona Virus Disease 2019 (COVID-19) Pneumonia and Hyper-inflammation

COVID

United States, Brazil, South Africa, Chile, Peru
Kaneka Corporation
ClinSearch

Unknown

Post Market Clinical Follow-Up for ED Coil / Electro-detach Generator v4

Arteriovenous Malformations | Aneurysm | Arterio-venous Fistula

Germany, Belgium
Kaneka Medical America LLC

Recruiting

Post Approval Study for Treatment of Drug-resistant Adult and Pediatric Primary FSGS Using the LIPOSORBER® LA-15 System (FSGSALLAGE)

Focal Segmental Glomerulosclerosis

United States
Hiroshima University
Kaneka Corporation

Completed

Effect of Chrysanthemum Flower Oil and Its Dose-dependency on Hyperuricemia

Hyperuricemia

Japan
Kaneka Medical America LLC

Recruiting

Kaneka Endovascular Embolization and Protection (KEEP)

Aneurysm Cerebral

United States
Kaneka Medical America LLC

Recruiting

Post Approval Study of Lixelle for the Treament of Dialysis-Related Amyloidosis

Dialysis Amyloidosis

United States
Kaneka Medical America LLC

Recruiting

Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children (FSGS pediatric)

Focal Segmental Glomerulosclerosis

United States
University of Rochester
Kaneka Corporation

Completed

Bioavailability of Ubiquinol in Huntington Disease

Huntington Disease

United States
Virginia Commonwealth University
Kiniksa Pharmaceuticals, Ltd.

Completed

Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation

COVID-19 | Pneumonia | Sars-CoV2

United States
The Cleveland Clinic
Kiniksa Pharmaceuticals, Ltd.

Completed

Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation

Pneumonia | SARS-CoV 2 | COVID 19

United States
University of Nottingham
Kaneka Corporation

Completed

Comparison of an Alginate Containing Enteral Feed and an Alginate Free Enteral Feed. (AlgiNG)

Enteral Nutrition

United Kingdom
Emory University
Kaneka Medical America LLC

Completed

Effects of Low-density Lipoprotein (LDL) Apheresis on Inflammatory and Lipid Markers (INFLAME)

Familial Hypercholesterolemia

United States
Massachusetts General Hospital
Kaneka Medical America LLC

Completed

Removal of Anti-Angiogenic Proteins in Preeclampsia Before Delivery (RAAPID-II)

Preeclampsia

Germany, United States
Massachusetts General Hospital
Kaneka Medical America LLC

Unknown

Assessing Bioavailability of CoQ10 Supplementation in Burn Patients (CoQ10)

Burn Injury

United States
Kristin Hudock
Kiniksa Pharmaceuticals, Ltd.

Unknown

Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflation

Pneumonia | SARS-CoV 2 | COVID 19

United States
Technische Universität Dresden
Kaneka Pharma Europe N.V.

Recruiting

Effect of Lipoprotein(a) Elimination by Lipoprotein Apheresis on Cardiovascular Outcomes (MultiSELECt)

Lipoprotein Types--Lp System Lp(A) Hyperlipoproteinemia

Germany
Kaneka Americas Holding Inc.
KGK Science Inc.

Completed

A Study Investigating the Effect of Floradapt Mature Immune Defense on Nutrient Uptake and Digestive Health in a Healthy Elderly Population

Healthy

Canada
Beth Israel Deaconess Medical Center
Kaneka Medical America LLC

Completed

Ubiquinol (Reduced COQ10) for Patients With Sepsis

Sepsis

United States
Icahn School of Medicine at Mount Sinai
Kaneka Corporation

Recruiting

Kaneka iED Coil System for the Treatment of Wide Necked Ruptured and Unruptured Intracranial Aneurysms (CLASS)

Intracranial Aneurysms | Wide Neck Intracranial Aneurysms

United States
Beth Israel Deaconess Medical Center
Kaneka Medical America LLC

Completed

Ubiquinol as a Metabolic Resuscitator in Post-Cardiac Arrest

Cardiac Arrest

United States
Children's Hospital Medical Center, Cincinnati
Kaneka Medical America LLC

Completed

LDL-Apheresis for FSGS CardioRenal Outcomes

Focal Segmental Glomerulosclerosis

United States
Comenius University
Sanatórium of Dr. Guhr, n.o.; Kaneka Pharma Europe N.V.

Completed

Spa Rehabilitation, Antioxidant and Bioenergetic Supportive Treatment of Patients With Post-Covid-19 Syndrome (SpaCOVID)

COVID-19 Respiratory Infection

Slovakia
Patrick Moriarty, MD, FACP, FACC
Kaneka Medical America LLC

Completed

Treating Congestive Heart Failure Using a Device to Remove Cholesterol

Heart Decompensation

United States
Heart Health Research Center

Not yet recruiting

Effect of Healthy Family Program on Population Blood Pressure

Blood Pressure
Heart Health Research Center
AstraZeneca

Completed

Compare the Impact of Xuezhikang and Atorvastatin on Glucose Metabolism in Dyslipidemia Patients With Prediabetes (XTREME)

Metabolism Disorder, Glucose | Metabolism Disorder, Lipid

China
Tokai University
Abbott Medical Devices; Kaneka Medical America LLC; Terumo Medical Corporation; Asahi Intech and other collaborators

Completed

Guidewire for Chronic Total Occlusion (G-FORCE)

Coronary Occlusion

Japan
Centre for Global eHealth Innovation
University Health Network, Toronto; Trillium Health Partners

Unknown

Adoption, Acceptability, and Effectiveness of a Mobile Health App for Personalised Prostate Cancer Survivorship Care.

Prostate Cancer

Canada
NYU Langone Health
American Heart Association; UNITE HERE Health Center

Terminated

Telephone-Based Lifestyle Intervention to Reduce Blood Pressure in Prehypertensive Patients

High Blood Pressure

United States
my mhealth Ltd
Expert Health Ltd; CLAHRC Wessex

Withdrawn

Integrated Digitally Enhanced Care for Long-term Conditions- Asthma (IDEAL)

Asthma

United Kingdom
LifeBridge Health
American Heart Association (AHA)

Completed

ConnectedHeartHealth - Heart Failure Readmission Intervention (CHH)

Coronary Artery Disease | Heart Failure | Diabetes Mellitus

United States
NYU Langone Health
American Heart Association

Not yet recruiting

HARP Mindfulness Study

Cardiovascular Diseases

United States
Spectrum Health Hospitals
West Michigan Heart

Completed

Clinical Outcomes of Three Different Percutaneous Revascularization Strategies for the Treatment of Lifestyle Limiting Claudication: A Retrospective Analysis (FIX-IT Retro)

Peripheral Artery Disease

United States
NYU Langone Health
American Heart Association

Completed

Platelet Activity in Vascular Surgery for Thrombosis and Bleeding (PIVOTAL)

Embolism and Thrombosis | Carotid Stenosis | Peripheral Vascular Disease | Peripheral Artery Disease | Aortic Aneurysm, Abdominal | Aortic Aneurysm | Aortic Aneurysm, Thoracic | Amputation, Wound

United States
NYU Langone Health
Blue Earth Diagnostics

Recruiting

Optimizing Timing of rhPSMA-7.3 (18F) for Assessing Site(s) of Recurrent Disease Following Radical Prostatectomy

Prostate Cancer

United States
NYU Langone Health
American Heart Association

Recruiting

Community-engaged Hypertension Prevention Program in Black Men

Hypertension

United States
NYU Langone Health
American Heart Association

Recruiting

The Retrain Your Brain for Healthy Eating Study

Obesity

United States
Montreal Heart Institute
Lallemand Health Solutions

Completed

Probiotics for Vascular Inflammation in Metabolic Syndrome (PROMISE)

Metabolic Syndrome

Canada

Clinical Trials Sponsored by Koneksa Health

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Liberia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations